An analysis of the dosimetry for mantle field therapy using 4 MV X-rays and its routine application.
There are several different methods in vogue at present in determining patient midplane doses in the "mantle" treatment for Hodgkin's disease and malignant lymphomas. A method of determining midplane doses in individual cases using thermoluminescent dosimetry is presented. It shows excellent agreement with the midplane doses measured in an Alderson-Rando phantom treated as a hypothetical "mantle" patient.